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Abstract
Albumin is the most abundant protein in human
serum. A dye-binding method is commonly used in
clinical laboratories for its estimation using different
types of dyes. However, all these dye methods were
interfered by a variety of compounds. Here we
present a method for the detection of albumin in
human serum and other biological fluids. The principle is based on the fact that lactate dehydrogenase
isoenzyme-5 (LDH-5) binds specifically to DextranBlue (DB). Albumin inhibits the binding of LDH-5
with DB. Absence of LDH activity in DB fraction after
gel filtration indicates the presence of albumin in
sample and vice versa.
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Introduction
Human serum albumin (HSA) is synthesized in liver and
is the most abundant protein in human serum, representing 40-60% of the total protein (Lindsey, 1996). The
earliest method for its determination involved the saltingout of the globulins with sodium sulfate, leaving the
albumin in solution (Silverman and Christenson, 1994).
The albumin was then determined by the Kjeldahol
method and, later, by the Biuret color development
(Gomes et al., 1998). The method commonly used today
is one involving dye binding and shift in color when a
dye is bound by albumin (Silverman and Christenson,
1994; Lindsey, 1996; Gomes et al., 1998). A variety of
dyes have been used, including methyl orange, 2-(4'hydroxyazobenzene) benzoic acid (HABA), bromocresol

green (BCG), and bromocresol purple (BCP) (Thakkar
et al., 1997; Kessler et al., 1997a). Methyl orange is
non-specific for albumin; β-lipoproteins and some α1and α2-globulins also bind to albumin and have a low
sensitivity (Kessler et al., 1997a). In addition, several
compounds such as salicylates, penicillin, conjugated
bilirubin, and sulfonamides, interfere with the binding of
albumin to the dye. Interfering substances such as
bilirubin and salicylates do not affect BCG; however,
hemoglobin can inhibit the binding of albumin to dye
(Kessler et al., 1997b). Even though BCG is the dye
most commonly used today, there are repeated reports
that the measurement of albumin by BCG overestimates
albumin levels (Karon et al., 1997). Several formats of
electrophoresis, radioimmunoassays (RIA) and immunoassays are available for albumin determination (Karon
et al., 1997; Kessler et al., 1997b), which are more
appropriate for body fluids in which albumin concentration is normally low (i.e., urine and CSF). The RIA and
immunoassays are relatively expensive and unlikely to
be applied except for special diagnostic purposes.
Recently, the albumin-blue (AB) series of fluorescent
albumin dyes have been described (Kessler et al.,
1997a). The limited solubility of the reagent solution so
far prevented its application in routine analysis. A new
derivative of AB, AB580, with improved solubility has
become available recently and is used in autoanalyser
for albumin determination in serum and urine (Karon et
al., 1997). Except for blood serum, albumin concentrations in body fluids such as urine are usually low and,
therefore, require sensitive and selective method for
their detection and estimation. Enzymes have been
extensively used nowadays in the analytical laboratories
due to their high specificity and sensitivity (Whitaker,
1991; Rej, 1998). In this study we present a simple
method for the detection of human albumin in biological
sample using LDH-5 and DB.

Materials and Methods
Chemicals
NADH, sodium pyruvate, Dextran Blue (DB), human
serum albumin (HSA), bovine serum albumin (BSA) and
potassium phosphate were from Sigma, St. Louis, U.S.A.
Sepharose-CL-6B gel was from Pharmacia-LKB Biotechnology, Uppsala, Sweden. The LDH-5 was purified
from rat liver as described elsewhere (Javed et al.,
1995). All biological fluids were obtained from the
clinical laboratory of the Aga Khan University Hospital
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(AKUH) and assayed after centrifugation within 3 days.
This study followed the protocol of the Human Subject
Protection Committee of AKUH and all volunteers were
informed prior to participation.
Principle of the assay
This assay is based on high affinity binding of DB with
LDH-5 (Leatherbarrow and Dean, 1980; Javed and
Naru, 1998; Javed et al., 1999). This binding of LDH-5
with DB was specifically inhibited by HSA (Javed and
Naru, 1998; Javed et al., 1999). The presence of the
LDH activity in DB fraction after gel filtration indicates
the absence of albumin while the absence of LDH
activity indicates the presence of albumin.
Procedure
The Sepharose-CL-6B gel was packed in column (17
cm × 0.5 cm) and equilibrated with 10 mM potassium
phosphate buffer containing 0.02% sodium azide, pH
7.5. One mg DB was added to 1 ml sample (± HSA) and
applied on top of the column. The microfractionator
(Gilson, Wisconsin, USA) collected one ml fractions and
the flow rate was controlled to about 40 ml/h by
Microperpex peristaltic pump (LKB, Ujppsala, Sweden).
To measure LDH activity, we added 465 µl of DB fraction
to 1ml cuvette. Twenty five µl substrate buffer (12 mM
sodium pyruvate and 1 M potassium phosphate pH 7.5)
were mixed and kept at 30oC for about 10 min. The
reaction was then started by adding 10 µl of 0.9 mM
NADH and the rate was monitored at 340 nm in
spectrophotometer (Beckman DU70, USA) for 2-3 min
(Javed et al., 1995; Javed and Naru 1998).

Results
In the presence of DB in the samples, LDH-5 co-eluted
with DB in void volume of sepharose column (Figure 1).
However, in the presence of HSA in samples along with
DB, LDH-5 activity was absent from DB fractions and
eluted in later fractions of column chromatography
(Figure 1). All human body fluids that contained albumin
(serum, albuminuric urine, plural fluid, ascites, peritonial
fluids, etc) showed no LDH-5 activity in DB fractions
after gel filtration and LDH-5 activity was observed in the
later fractions. The minimum volume of normal human
serum needed to completely block the LDH-5 binding
with DB was found to be 2 µl, that equals to be about
0.08 mg of albumin. We tried to estimate the albumin by
calibrating a standard curve but we could not reproduce
the results. By adding serum to DB-LDH samples from
animals (i.e., animal albumin) like sheep, rabbit, mouse,
rat, hamster and pigeon, the DB-LDH complex appeared in void volume. There was no effect on binding of DB
with LDH-5 even up to 40 mg/ml of animal albumin.
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Figure 1. Gel filtration of DB-LDH-complex in the presence ( - ) and
absence ( - ) of human serum albumin. The method is described in the
text. DB peak is shown as ( - ) which is eluted in the void volume. The
pattern of the Fig was like ( - ) when we added the serum in the samples
from various animal species or BSA as mentioned in the results.
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Similarly there was no effect of BSA on the binding of
DB with LDH-5.

Discussion
Various methods have been used for the detection of
albumin in different biological samples (Karon et al.,
1997; Kessler et al., 1997a; Kessler et al., 1997b; Thakkar
et al., 1997). Each method has some merits and demerits
and the major drawback is the interference by other
proteins and metabolites (Kessler et al., 1997a). Here,
we described a new method for the detection of HSA.
We believe that the gel filtration method is more specific
than the dye binding methods (Karon et al., 1997;
Kessler et al., 1997a; Kessler et al., 1997b; Thakkar et
al., 1997) because the DB specifically binds to LDH-5
and it does not have any affinity even for LDH-1.
Similarly, the HSA specifically compete with the binding
of LDH-5 with DB and albumin from other animals and
other serum proteins from human serum do not compete
with binding of DB with LDH-5 (Leatherbarrow and
Dean, 1980). We have also observed that the binding of
DB with LDH-5 is inhibited only by HSA, as the serum
from animals, like sheep, rabbit, mouse, rat, hamster
and pigeon (which contained animal albumin and not
human albumin) were unable to block the binding of
LDH-5 with DB and LDH activity appeared in the void
volume in the presence of even up to 40 mg/ml of
animal albumin (speculating that these animal serum
also have about 4 gm/dl of albumin with total serum
protein as about 6-8 gm/dl). This method is more simple
and sensitive to detect micro quantity of albumin. The
same gel has been used for many months and even
can be used for many years in the presence of 0.02%
sodium azide. Furthermore, LDH-5 can easily be purified in large quantities from rat liver (Javed et al., 1995)
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and was found to be stable for years at 4oC.
In conclusion, the detection of HSA in biological fluids
by this method is more specific relative to dye binding
methods and can be applied in many pathological
conditions. The dye binding and electrophoresis are
standard but need special equipments, which may not
be available in ordinary clinical laboratories, particularly
in developing countries. Furthermore this new assay for
HSA detection is a useful addition to the analytical
sciences.
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